Genetic testing hopes to speed up drug development in rare eye diseases
eye disease, genetic testing, IRD, ProQR Therapeutics, Rare diseases
0 Comment
eye disease
NICE rejects rare eye disease therapy
Dompé, eye disease, market access, NICE, ophthalmology
0 Comment
Other treatment option is disfiguring eyelid operation
Living with LHON: Achieving your dreams in the dark
eye disease, hereditary eye disease, LHON, mitochondrial disease, rare disease
0 Comment
When Fabrizio Sottile went blind at the age of 17, he thought his dreams of becoming a world-class swimmer were over. But he wasn’t about to let Leber’s hereditary optic neuropathy (LHON) stand in his way, and he made his first appearance as part of Italy’s Paralympic team in 2016, aged 23.
LHON in the family: living under the spectre of an hereditary eye disease
eye disease, hereditary eye disease, LHON, LHON awareness, LHON Society, mitochondrial disease, patient perspective, patients, rare disease
0 Comment
Out of the darkness: new gene therapies for eye diseases
eye disease, gene therapy, inherited disease, patient perspective, rare disease, Spark Therapeutics
0 Comment
US FDA expert committee’s ‘yes’ could pave the way for a new generation of gene therapies for rare inherited eye disorders.